M. Ángela Aznar

Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti–PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells

Alfonso R. Sánchez-Paulete, Francisco J. Cueto, María Martínez‐López et al. · Cancer Discovery · 2015 · 461 citations · Full text

An NK-like CAR T cell transition in CAR T cell dysfunction

Charly R. Good, M. Ángela Aznar, Shunichiro Kuramitsu et al. · Cell · 2021 · 376 citations · Full text

Autoimmune Disease, T-regulatory Cell, Immunology +7

Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells

Sangya Agarwal, M. Ángela Aznar, Andrew J. Rech et al. · Immunity · 2023 · 151 citations · Full text

A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity

Marta Compte, Seandean L. Harwood, Inés G. Muñoz et al. · Nature Communications · 2018 · 141 citations · Full text

Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8+ T Cells

Iñaki Etxeberría, Elixabet Bolaños, José I. Quetglas et al. · Cancer Cell · 2019 · 132 citations · Full text

Cell Therapy, Il-12 Mrna, Cancer Immunosurveillance +7